Induction of class i major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection

Cancer Research

Volumn 47, Issue 3, 1987, Pages 740-746

  Baglioni, Corrado ^b   Perussia, Bice ^a  

^a WISTAR INSTITUTE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

CANCER IMMUNOTHERAPY; CHORIOCARCINOMA; DRUG RESISTANCE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TERATOMA; TERATOMA CELL; THERAPY; VIRUS INFECTION;

ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, VIRAL; HUMAN; INTERFERON TYPE I; INTERFERON TYPE II; MAJOR HISTOCOMPATIBILITY COMPLEX; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TERATOMA; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0023118153     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Isaacs, A., and Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Ser. B. (Lond), 147:258-267, 1957.
2. Friedman, R. M., and Vogel, S. N. Interferons with special emphasis on the immune system. Adv. Immunol., 34:97-140, 1983.
3. Rosa, F., and Fellous, M. The effect of gamma-interferon on MHC antigens. Immunol. Today, 5:261-262,1984.
4. Trinchieri, G., and Perussia, B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today, 6: 131–136, 1985.
5. Perussia, B., Dayton, E. T., Fanning, V., Thiagarajan, P., Hoxie, J., and Trinchieri, G. Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J. Exp. Med., 158:2058-2080, 1983.
6. Dolei, A., Colletta, G., Capobianchi, M. R., Rossi, G. B., and Vecchio, G. Interferon effects on Friend leukemia cells. I. Expression of virus and erythroid markers in untreated and dimethylsulphoxide-treated cells. J. Gen. Virol., 46:227-236,1980.
7. Keay, S., and Grossberg, S. E. Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc. Natl. Acad. Sci. USA, 77: 4099–4103, 1980.
8. Drasner, K., Epstein, C. J., and Epstein, L. B. The antiproliferative effects of interferon on murine embryonic cells. Proc. Soc. Exp. Biol. Med., 160: 46–49, 1979.
9. Barlow, D. P., Randle, B. J., and Burke, D. C. Interferon synthesis in the early post-implantation mouse embryo. Differentiation, 27:229-235, 1984.
10. Burke, D. C., Graham, C. F., and Lehman, J. M. Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro. Cell, 13:243-248,1978.
11. Wood, J. N., and Hovanessian, A. G. Interferon enhances 2-5A synthetase in embryonal carcinoma cells. Nature (Lond.), 282:74-76,1979.
12. Solter, D., and Damjanov, I. Teratocarcinoma and the expression of oncodevelopmental genes. Methods Cancer Res., 18:277-332,1979.
13. Martin, G. R. Teratocarcinomas and mammalian embryogenesis. Science (Wash. DC), 209:768-776,1980.
14. Nilsen, T. W., Wood, D. L., and Baglioni, C. Virus-specific effects of interferon in embryonal carcinoma cells. Nature (Lond.), 286: 178–180, 1980.
15. Andrews, P. W., Goodfellow, P. N., and Damjanov, I. Human teratocarcinoma cells in culture. Cancer Surv., 2:41-73,1983.
16. Andrews, P. W., Bronson, D. L., Benham, F., Strickland, S., and Knowles, B. B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int. J. Cancer, 26:269-280,1980.
17. Andrews, P. W., Bronson, D. L., Wiles, M. V., and Goodfellow, P. N. The expression of major histocompatibility antigens by human teratocarcinoma derived cell lines. Tissue Antigen, 17:493-500, 1981.
18. Andrews, P. W., Goodfellow, P. N., Shevinsky, L., Bronson, D. L., and Knowles, B. B. Cell surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer, 29:523-531, 1982.
19. Damjanov, I., Fox, N., Knowles, B. B., Solter, D., Lange, P. H., and Fraley, E. E. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. Am. J. Pathol., 108: 225–230, 1982.
20. Andrews, P. W., Damjanov, I., Simon, D., Banting, G., Carlin, C., Dracopoli, N. C., and Fogh, J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line TERA-2: differentiation in vivo and in vitro. Lab. Invest., 50: 147-162,1984.
21. Vogelzang, N. J., Bronson, D., Savino, D., Vessella, R. L., and Fraley, E. E. A human embryonal-yolk sac carcinoma model system in athymic mice. Cancer (Phila.), 55:2584-2593, 1985.
22. Pattillo, R. A., Ruckert, A., Hussa, R. O., Bernstein, R., and Delfs, E. The cell line Jar—continuous human multihormone production and controls. In Vitro (Rockville), 6:398-399, 1971.
23. Andrews, P. W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol., 103: 285–293, 1984.
24. Nelson-Rees, W. A., and Flandermeyer, R. R. Hela cultures defined. Science (Wash. DC), 191:96-98, 1976.
25. Solter, D., and Knowles, B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA, 75: 5565–5569, 1978.
26. Shevinsky, L. H., Knowles, B. B., Damjanov, I., and Solter, D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell, 30: 697-705,1982.
27. Andrews, P. W., Meyer, L. J., Bednarz, K. L., and Harris, H. Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozymes of human alkaline phosphatase. Hybridoma, 3:33-39, 1984.
28. Eisenbarth, G. S., Walsh, F. S., and Nirenberg, M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA, 76: 4913-4917,1979.
29. Thurin, J., Herlyn, M., Hindsgaul, O., Stromberg, N., Karlsson, K. A., Elder, D., Steplewski, Z., and Koprowski, H. Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. J. Biol. Chem., 160:14556-14563,1985.
30. Griffin, J. D., Hercend, T., Beveridge, R., and Schlossman, S. F. Characterization of an antigen expressed by human natural killer cells. J. Immunol., 130:2947-2951,1983.
31. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F., and Ziegler, A. Production of monoclonal antibodies to Group A erythrocytes, HLA, and other human cell surface antigens-new tools for genetic analysis. Cell, 14:9-20, 1978.
32. Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., and Bodmer, W. F. Monoclonal antibodies for analysis of the HLA system. Immunol. Rev., 47: 3–61, 1979.
33. Accolla, R. S., Gross, N., Carrel, S., and Corte, G. Distinct forms of both aand β-subunits are present in the human la molecular pool. Proc. Natl. Acad. Sci. USA, 78:4549-4551, 1981.
34. Lemke, H., Hammerling, G. J., and Hammerling, U. Fine specificity analysis with monoclonal antibody of antigens controlled by the mqjor histocompatibility complex and by the Qa/Tla region in mice. Immunol. Rev., 47: 175–206, 1979.
35. Oi, V. T., Jones, P. P., Goding, J. W., and Herzenberg, L. A. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and la antigens. Curr. Top. Microbiol. Immunol., 81:115-129, 1978.
36. Wall, K. A., Lorber, M. I., Loken, M. R., McClatchey, S., and Fitch, F. W. Inhibition of proliferation of Mis- and la-reactive cloned T.-cells by a monoclonal antibody against a determinant shared by I-A and I-E. J. Immunol., 131:1056-1064,1983.
37. Kohler, G., and Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (Lond.), 256:495-497, 1975.
38. Reed, L. J., and Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Hygiene, 27:493-497, 1938.
39. Andrews, P. W., Daiqjanov, I., Simon, D., and Dignazio, M. A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor. Differentiation, 29:127-135, 1985.
40. Andrews, P. W. Properties of cloned human embryonal carcinoma cells and their differentiation in vitro. In: W. G. Jones, A. Milford-Ward, and C. K. Anderson (eds.), Germ Cell Tumours II, pp. 71–75. Oxford: Pergamon Press, 1985.
41. Lee, V. M. Y., and Andrews, P. W. Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J. Neurosci., 6:514-521,1986.
42. Matthaei, K., Andrews, P. W., and Bronson, D. L. Retinoic acid fails to induce differentiation in human teratocarcinoma cell lines that express high levels of cellular receptor protein. Exp. Cell Res., 143:471-474,1983.
43. Schwartz, R., Momburg, F., Moldenhauer, G., Dorken, B., and Schirrmacher, V. Induction of HLA Class II antigen expression on human carcinoma cell lines by IFN-gamma. Int. J. Cancer, 35:245-250,1985.
44. Frohman, M. A. Major histocompatibility complex la expression and antigen presentation. Ph.D. Thesis, University of Pennsylvania, 1985.
45. Solter, D., Shevinsky, L., Knowles, B. B., and Strickland, S. The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. Dev. Biol., 70:515-521,1979.
46. Anderson, D. J., and Berkowitz, R. S. γ-Interferon enhances expression of Class I MHC antigens in the weakly HLA+human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA-choriocarcinoma cell line Jar. J. Immunol., 135:2498-2501,1985.
47. Artzt, K., and Jacob, F. Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture. Transplantation (Baltimore), 17:632-634, 1974.
48. Morello, D., Gachelin, G., Dubois, P., Tanigaki, N., Pressman, D., and Jacob, F. Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells. Transplantation (Baltimore), 26:119-125,1978.
49. Croce, C. M., Linnenbach, A., Huebner, K., Paines, J. R., Margulies, D. H., Appella, E., and Seidman, J. G. Control of expression of histocompatibility antigens (H-2) and β2-microglobulin in F9 teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 78:5754-5758, 1981.
50. Andrews, P. W., and Goodfellow, P. N. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L-cells. Somatic Cell Genet, 6:271-284, 1980.
51. Miller, R. A., and Ruddle, F. H. Properties of teratocarcinoma-thymus somatic cell-hybrids. Somatic Cell Genet., 3:247-261,1977.
52. Lieberman, R., Orrison, B., and Ozato, K. Induction of MHC Class I antigen expression in mouse embryonal carcinoma cells (EEC) and in placenta derived cells by gamma interferon (IFN-gamma). Fed. Proc., 44:1689,1985.
53. Aguet, M., Grosser, I., Hovanessian, A. G., Bandu, M. T., Blanchard, B., and Blangy, D. Specific high-affinity binding of 129I-labeled mouse interferon to interferon resistant embryonal carcinoma cells in vitro. Virology, 114: 585-588,1981.
54. Krause, D., Silverman, R. H., Jacobsen, H., Leisy, S. A., Dieffenboch, C., and Friedman, R. M. Regulation of ppp(A2'p)nA-dependent RNase levels during interferon treatment and cell differentiation. Eur. J. Biochem., 146: 611-618,1985.
55. Gachelin, G., Kemler, R., Kelly, F., and Jacob, F. PCC4, a new cell surface antigen common to multipotential embryonal carcinoma cells, spermatozoa, and mouse early embryos. Dev. Biol., 57:199-209,1977.
56. Thompson, S., Stem, P. L., Webb, M., Walsh, F. S., Engstrom, W., Evans, E. P., Shi, W. K., Hopkins, B., and Graham, C. F. Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid. J. Cell Sci., 72:37-64,1984.
57. Moser, A. R., Johnson, L. L., and Dove, W. F. Mice co-isogenically immunized against H-2 Class I antigens on transfected L-cells reject transplanted embryonal carcinoma cells. Immunogenetics, 22:533-541,1985.
58. Ostrand-Rosenberg, S., and Cohan, V. L. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice. J. Immunol., 126:2190-2193,1981.
59. Nicolas, J.-F., Dubois, P., Jakob, H., Gaillard, J., and Jacob, F. Tératocar-cinome de la souris: différentiation en culture d'une lignée de cellules primitives à potentialités multiples. Ann. Microbiol. (Inst. Pasteur), 126A: 3–22, 1975.
60. Jakob, H., Boon, T., Gaillard, J., Nicolas, J.-F., and Jacob, F. Tératocarrinome de la souris: isolement, culture, et propriétés de cellules à potentialités multiples. Ann. Microbiol. (Inst. Pasteur), 124B: 269-282,1973.
61. Bemstine, E. G., Hooper, M. L., Grandchamp, S., and Ephrussi, B. Alkaline phosphatase activity in mouse teratoma. Proc. Natl. Acad. Sci. USA, 70: 3899-3902,1973.
62. Benham, F. J., Wiles, M. V., Banting, G., Andrews, P. W., and Goodfellow, P. N. Human-mouse teratocarcinoma hybrids: a tool for analysis of gene activity in early human development. In: I. Damjanov, B. B. Knowles, and D. Solter (eds.), The Human Teratomas: Experimental and Clinical Biology, pp. 313–341. Clifton, NJ: Human Press, 1983.
63. Lehman, J. M., Speers, W. C., Swartzendruber, D. E., and Pierce, G. B. Neoplastic differentiation: characteristics of cell lines derived from a murine teratocarcinoma. J. Cell. Physiol., 84:13-28,1974.
64. Knowles, B. B., Koncar, M., Pfizenmaier, K., Solter, D., Aden, D. P., and Trinchieri, G. Genetic control of the cytotoxic T-cell response to SV-40 tumor associated specific antigen. J. Immunol., 122:1798-1806,1979.